- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Intravenous immunoglobulin and Alzheimer’s disease: what now? ; volume:10 ; number:1 ; day:5 ; month:6 ; year:2013 ; pages:1-7 ; date:12.2013
Journal of neuroinflammation ; 10, Heft 1 (5.6.2013), 1-7, 12.2013
- Creator
-
Loeffler, David A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1742-2094-10-70
- URN
-
urn:nbn:de:1111-2016032334383
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Loeffler, David A.
- SpringerLink (Online service)
Other Objects (12)
Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?
Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer’s disease
Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease
Early-Onset Alzheimer’s Disease: What Is Missing in Research?
Early and late-onset Alzheimer’s disease: What are the differences?
Increased plasma and brain immunoglobulin A in Alzheimer’s disease is lost in apolipoprotein E ε4 carriers
Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
Alzheimer’s Disease
The gut microbiome in Alzheimer’s disease: what we know and what remains to be explored
Alzheimer
Alzheimer
Assessing What Matters to People Affected by Alzheimer’s Disease: A Quantitative Analysis
Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?
Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer’s disease
Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease
Early-Onset Alzheimer’s Disease: What Is Missing in Research?
Early and late-onset Alzheimer’s disease: What are the differences?
Increased plasma and brain immunoglobulin A in Alzheimer’s disease is lost in apolipoprotein E ε4 carriers
Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
Alzheimer’s Disease
The gut microbiome in Alzheimer’s disease: what we know and what remains to be explored
Alzheimer
Alzheimer
Assessing What Matters to People Affected by Alzheimer’s Disease: A Quantitative Analysis
Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?
Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer’s disease
Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease
Early-Onset Alzheimer’s Disease: What Is Missing in Research?
Early and late-onset Alzheimer’s disease: What are the differences?
Increased plasma and brain immunoglobulin A in Alzheimer’s disease is lost in apolipoprotein E ε4 carriers
Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
Alzheimer’s Disease
The gut microbiome in Alzheimer’s disease: what we know and what remains to be explored
Alzheimer
Alzheimer